MY155338A - Novel insulin derivatives having an extremely delayed time-action profile - Google Patents

Novel insulin derivatives having an extremely delayed time-action profile

Info

Publication number
MY155338A
MY155338A MYPI2010002667A MYPI20102667A MY155338A MY 155338 A MY155338 A MY 155338A MY PI2010002667 A MYPI2010002667 A MY PI2010002667A MY PI20102667 A MYPI20102667 A MY PI20102667A MY 155338 A MY155338 A MY 155338A
Authority
MY
Malaysia
Prior art keywords
action profile
delayed time
insulin derivatives
novel insulin
extremely delayed
Prior art date
Application number
MYPI2010002667A
Inventor
Habermann Paul
Seipke Gerhard
Kurrle Roland
Müller Günter
Sommerfeld Mark
Tennagels Norbert
Tschank Georg
Werner Ulrich
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE200810003556 external-priority patent/DE102008003556A1/en
Priority claimed from DE200810025007 external-priority patent/DE102008025007A1/en
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of MY155338A publication Critical patent/MY155338A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

THE INVENTION RELATES TO NOVEL INSULIN ANALOGS HAVING A BASAL TIME-ACTION PROFILE, WHICH ARE CHARACTERIZED BY THE ADDITION AND/OR SUBTITUTION OF NEGATIVELY AND POSITIVELY CHARGED AMINO ACID RESIDUES AND BY AN AMIDATION OF THE C-TERMINAL CARBOXY GROUP OF THE B CHAIN AND HISTIDINE IN POSITION 8 OF THE INSULIN A CHAIN. THE INVENTION ALSO RELATES TO THE PRODUCTION AND USE THEREOF.
MYPI2010002667A 2008-01-09 2009-01-06 Novel insulin derivatives having an extremely delayed time-action profile MY155338A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE200810003556 DE102008003556A1 (en) 2008-01-09 2008-01-09 blister
US4466208P 2008-04-14 2008-04-14
DE200810025007 DE102008025007A1 (en) 2008-05-24 2008-05-24 Insulin analogs which comprise A chain and B chain with disulfide bonds for use in treatment of diabetes and for cartilage regeneration

Publications (1)

Publication Number Publication Date
MY155338A true MY155338A (en) 2015-10-15

Family

ID=54779999

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2010002667A MY155338A (en) 2008-01-09 2009-01-06 Novel insulin derivatives having an extremely delayed time-action profile

Country Status (1)

Country Link
MY (1) MY155338A (en)

Similar Documents

Publication Publication Date Title
WO2009087082A3 (en) Novel insulin derivatives having an extremely delayed time-action profile
IN2014DN03424A (en)
TN2010000298A1 (en) Novel insulin derivatives having an extremely delayed time-action profile
UA103015C2 (en) Novel insulin derivatives having an extremely delayed time-action profile
UA118167C2 (en) Peptides and their use
NZ601374A (en) Stabilized antibody-containing liquid formulations
MX359680B (en) Peptide vaccines for cancers expressing tumor-associated antigens.
WO2013098802A3 (en) Solid phase peptide synthesis via side chain attachment of hydroxyl amino acids
MY151985A (en) Dental wipe
HK1202067A1 (en) Therapeutic agents comprising insulin amino acid sequences
MX2010004571A (en) Wo 2009100260 a2 20090813.
NZ743910A (en) Purification of iduronate-2-sulfatase
WO2013000922A9 (en) Ccr2 antagonist peptides
IN2014DN09367A (en)
GB201118201D0 (en) Novel peptides
AR128395A2 (en) NOVEL PEPTIDES ABLE TO INDUCE THE FORMATION OF ANTIBODIES AGAINST PCSK9
MX2013008699A (en) Compounds for the reduction of î²-amyloid production.
WO2010003828A3 (en) Antiperspirant products
EA033145B1 (en) Use of pedf-derived polypeptides for promoting muscle or tendon regeneration or arteriogenesis
SG10201805039UA (en) Protease resistant peptides
GB201110815D0 (en) Incorporation of subtituted lysines into polypeptides
WO2013021284A3 (en) Anti-il-6 vaccine composition
MX2013014401A (en) Shk-based pharmaceutical compositions and methods of manufacturing and using the same.
MX2015002279A (en) Synthetic pntx(19) peptide, pharmaceutical compositions and use.
MX2010010177A (en) Improved beta thymosin fragments.